140 related articles for article (PubMed ID: 10662601)
1. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol).
Li S; Ouyang Y; Yang GH; Pestka JJ
Toxicol Appl Pharmacol; 2000 Feb; 163(1):17-25. PubMed ID: 10662601
[TBL] [Abstract][Full Text] [Related]
2. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells.
Ouyang YL; Li S; Pestka JJ
Toxicol Appl Pharmacol; 1996 Oct; 140(2):328-36. PubMed ID: 8887449
[TBL] [Abstract][Full Text] [Related]
3. Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells.
Wong SS; Zhou HR; Pestka JJ
J Toxicol Environ Health A; 2002 Aug; 65(16):1161-80. PubMed ID: 12167214
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol).
Yang GH; Li S; Pestka JJ
Toxicol Appl Pharmacol; 2000 Feb; 162(3):207-17. PubMed ID: 10652249
[TBL] [Abstract][Full Text] [Related]
5. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
6. Superinduction of IL-2 gene expression by vomitoxin (deoxynivalenol) involves increased mRNA stability.
Li S; Ouyang YL; Dong W; Pestka JJ
Toxicol Appl Pharmacol; 1997 Dec; 147(2):331-42. PubMed ID: 9439728
[TBL] [Abstract][Full Text] [Related]
7. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
[TBL] [Abstract][Full Text] [Related]
8. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells.
Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G
Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991
[TBL] [Abstract][Full Text] [Related]
9. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
10. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
Lin CW; Robbins PD; Georgescu HI; Evans CH
Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
[TBL] [Abstract][Full Text] [Related]
11. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters.
Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH
Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
13. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
14. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
15. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
[TBL] [Abstract][Full Text] [Related]
16. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
17. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
18. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Kim R; Beck WT
Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
[TBL] [Abstract][Full Text] [Related]
19. Altered AP-1 (activating protein-1) activity and c-jun activation in T cells exposed to the amide class herbicide 3,4-dichloropropionanilide (DCPA).
Brundage KM; Schafer R; Barnett JB
Toxicol Sci; 2004 May; 79(1):98-105. PubMed ID: 14976341
[TBL] [Abstract][Full Text] [Related]
20. Activator protein accelerates dihydropyrimidine dehydrogenase gene transcription in cancer cells.
Ukon K; Tanimoto K; Shimokuni T; Noguchi T; Hiyama K; Tsujimoto H; Fukushima M; Toge T; Nishiyama M
Cancer Res; 2005 Feb; 65(3):1055-62. PubMed ID: 15705907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]